Showing results (151-160 of 3,147) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|September 2, 2025
Genomics correlates of brain metastasis and progression in colorectal cancerChengcheng Gui, Henry S Walch, Kirin D Mueller, et al.
Neuro-Oncology|May 27, 2015
CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma modelsMasashi Chonan, Ryuta Saito, Takuhiro Shoji, et al.
Neuro-Oncology|May 13, 2021
MEF2C silencing downregulates NF2 and E-cadherin and enhances Erastin-induced ferroptosis in meningiomaZhongyuan Bao, Lingyang Hua, Yangfan Ye, et al.
Neuro-Oncology|August 4, 2021
ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in gliomaHua Huang, Maria Georganaki, Lei Liu Conze, et al.
Neuro-Oncology|August 12, 2021
Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?Jasmin Jo, Joseph Donahue, Guneet Sarai, et al.
Neuro-Oncology|February 22, 2023
Cognitive outcomes after multimodal treatment in adult glioma patients: A meta-analysisLaurien De Roeck, Céline R Gillebert, Robbie C M van Aert, et al.
Neuro-Oncology|March 27, 2001
Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II studyD H Mahoney, M E Cohen, H S Friedman, et al.
Neuro-Oncology|March 27, 2001
Posttransplant primary CNS lymphomaT G Phan, B P O'Neill, P J Kurtin
Neuro-Oncology|March 27, 2001
Primary Hodgkin's disease of the CNS in an immunocompetent patient: a case study and review of the literatureJ Biagi, R G MacKenzie, M S Lim, et al.
Neuro-Oncology|March 11, 2003
A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952Seema N Sanghavi, Michael N Needle, Mark D Krailo, et al.
Pageof 315